Litigation Details for Silvergate Pharmaceuticals, Inc. v. Bionpharma Inc. (D. Del. 2019)
✉ Email this page to a colleague
Silvergate Pharmaceuticals, Inc. v. Bionpharma Inc. (D. Del. 2019)
| Docket | ⤷ Start Trial | Date Filed | 2019-06-07 |
| Court | District Court, D. Delaware | Date Terminated | 2021-05-17 |
| Cause | 35:271 Patent Infringement | Assigned To | |
| Jury Demand | None | Referred To | |
| Parties | SILVERGATE PHARMACEUTICALS, INC. | ||
| Patents | 10,039,745; 10,154,987; 8,568,747; 8,778,366; 9,616,096; 9,669,008; 9,808,442; 9,968,553 | ||
| Attorneys | Matthew R. Reed | ||
| Firms | Morris, Nichols, Arsht & Tunnell | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Silvergate Pharmaceuticals, Inc. v. Bionpharma Inc.
Details for Silvergate Pharmaceuticals, Inc. v. Bionpharma Inc. (D. Del. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2019-06-07 | External link to document | |||
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
